Thrombectomy less beneficial in large-core stroke
UC expert comments on trial results to Medscape
Thrombectomy, a minimally invasive stroke procedure that uses a catheter to remove a blood clot from a blood vessel in the brain to restore blood flow, has been shown to be beneficial in patients with large-core ischemic stroke.
But a secondary analysis of data from the randomized SELECT2 trial recently showed that patients with the greatest volume of tissue injury may benefit less from the procedure.
The analysis used imaging and outcome data from the 322 patients with large-core ischemic stroke included in the trial to look at whether the occurrence of severe hypodensity modified the effect of thrombectomy.
The results showed that as the volume of severe hypodensity increased, the odds of a favorable outcome with thrombectomy decreased.
The University of Cincinnati's Joseph Broderick, MD, commented on the study findings to Medscape.
"These data, if validated, provide a more fine-tuned approach to the use of endovascular therapy in patients with larger volumes of ischemic core," said Broderick, professor in the University of Cincinnati’s Department of Neurology and Rehabilitation Medicine in the College of Medicine and director of the UC Gardner Neuroscience Institute.
Broderick explained that greater intensity of hypodensity has been recognized as a marker for a greater likelihood of unsalvageable brain.
"There are some parallels with diffusion/flair mismatch that have been used to identify patients who may benefit from reperfusion," he said. "The next step will be to test these parameters in other published and reported large-core trials, but time to first image and time to treatment will be important variables to be considered in validating these data and incorporating them into clinical practice."
Featured photo at top of Dr. Broderick. Photo/Joseph Fuqua II/University of Cincinnati
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.